1.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSGCC-0307, NCI-6015, 6015, NCT00079443
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTC-0303, NABTC-03-03, NCT00085540, NCI-05-C-0098
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GPI-06-0003, NCT00379639
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-00-C-0123, NCI-1053, 1053, NCT00020202
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-01-C-0049, 01-C-0049, NCI-1312, NCT00020436, 1312
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-00116, NCI-1715, 1715, NCT00042822
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-12209B, NCI-5965, NCT00062075, 5965
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: AECM-0403765, NCI-5996, NCT00066638, 5996
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-MC0287, NCI-5961, 5961, NCT00077194
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: SWOG-S0336, S0336, NCT00077337
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-2003C0085, NCI-6325, 6325, NCT00084461
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: AECM-02025, NYWCCC-02025, 6335, NYWCCC-0402025S, NCI-6335, DFCI-04358, NCT00084682
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-12965, 6347, LUMC-106995, NCI-6347, NCT00085527
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-30304, NCT00086827
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S0400, S0400, NCT00087295
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: CCCWFU-83403, 6321, NCI-6321, NCT00091195
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-04059, NCI-6338, 6338, NCT00098813
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-6075-04-7R0, NCI-6351, 6351, NCT00098527
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-2003-0895, 6369, NCI-6369, NCT00098397
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E1603, E1603, NCT00104884
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FJ-228-0002, NCT00106418
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCCWFU-71103, 6319, NCT00112463, CCCWFU 71103
|
|
23.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GUMC-95066, GUMC-T95-0022, NCI-T95-0022D, T95-0022
|
|
24.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-97-C-0135G, NCI-T95-0077, NCT00019318, T95-0077
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-00H0350, NCI-27, NCT00024180, 27
|
